Drug-induced cholestasis

Journal of Hepatology, Supplement

Volumn 26, Issue 1, 1997, Pages 1-4

  Erlinger, Serge ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DRUG; FLOXURIDINE;

ANIMAL; CHEMICALLY INDUCED DISORDER; CHOLELITHIASIS; CHOLESTASIS; HUMAN; LIVER; METABOLISM; REVIEW; SCLEROSING CHOLANGITIS;

ANIMALS; BILE ACIDS AND SALTS; CHOLANGITIS, SCLEROSING; CHOLELITHIASIS; CHOLESTASIS; FLOXURIDINE; HUMANS; LIVER; PHARMACEUTICAL PREPARATIONS;

EID: 0030629746     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)82326-4     Document Type: Article

References (11)

1. Erlinger S. New insights into the mechanisms of hepatic transport and bile secretion. J Gastroenterol Hepatol 1996; 11: 575-9.
2. Larrey D, Erlinger S. Drug-induced cholestasis. In: Bircher J, ed. Adverse drug reactions in the differential diagnosis of GI and liver diseases. Clin Gastroenterol 1988; 2: 423-52.
3. Stricker BHC. Drug-induced Hepatic Injury, 2nd edn. Amsterdam: Elsevier, 1992.
4. Kowdley KV, Keeffe EB, Fawaz KA. Prolonged cholestasis due to trimethoprim-sulfamethoxazole. Gastroenterology 1992; 106: 2148-50.
5. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992; 15: 244-51.
6. Larrey D, Michel H. Pathologie biliaire liée aux médicaments. Gastroenterol Clin Biol 1993; 17: H59-65.
7. Davies MH, Harrison RF, Elias E, Hubscher SG. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994; 20: 112-6.
8. Moradpour D, Altorfer J, Flury R, Greminger, Meyenberger C, Jost R, Schmid M. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 1994; 20: 1437-41.
9. Koek GH, Stricker BH, Blok AP, Schalm SW, Desmet VJ. Flucloxacillin-associated hepatic injury. Liver 1994; 14: 225-9.
10. Devereaux BM, Crawford DH, Purcell P, Powell LW, Roeser HP. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? Eur J Clin Pharmacol 1995; 49: 81-5.
11. Ryley NG, Fleming KA, Chapman RW. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin®). J Hepatol 1995; 23: 278-82.